Mycophenolate Mofetil;A Review of Indications and Use in a Large Tertiary Hospital

Mycophenolate Mofetil (MMF) has been registered for use in Australia since 1997 for prophylaxis of solid organ allograft rejection. MMF is now increasingly used for indications outside solid organ allograft rejection, often with limited supporting efficacy data. The purpose of this audit was to exam...

Full description

Bibliographic Details
Main Authors: Nimeshan Geevasinga, Lucinda Wallman, Constance H. Katelaris
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2005-12-01
Series:Iranian Journal of Allergy, Asthma and Immunology
Subjects:
Online Access:https://ijaai.tums.ac.ir/index.php/ijaai/article/view/116